Journal article

Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein

JH Fox, T Connor, M Stiles, J Kama, Z Lu, K Dorsey, G Liebermann, E Sapp, RA Cherny, M Banks, I Volitakis, M DiFiglia, O Berezovska, AI Bush, SM Hersch

Journal of Biological Chemistry | AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC | Published : 2011

Abstract

Huntington disease (HD) is a progressive neurodegenerative disorder caused by expression of polyglutamine-expanded mutant huntingtin protein (mhtt). Most evidence indicates that soluble mhtt species, rather than insoluble aggregates, are the important mediators of HD pathogenesis. However, the differential roles of soluble monomeric and oligomeric mhtt species in HD and the mechanisms of oligomer formation are not yet understood. We have shown previously that copper interacts with and oxidizes the polyglutamine-containing N171 fragment of huntingtin. In this study we report that oxidation-dependent oligomers of huntingtin form spontaneously in cell and mouse HD models. Levels of these specie..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institute of Neurological Disorders and Stroke


Funding Acknowledgements

This work was supported, in whole or in part, by National Institutes of Health Grants NS045806 (to S. H.), 5P20RR015640-10 (to University of Wyoming Neuroscience COBRE), and 1R21NS072372 (to J. F.). This work was also supported by Huntington's Disease Society of America awards (to S. H. (Coalition for the Cure) and J. F.) and also by the Cure Huntington's Disease initiative (to S. H.).